£68.00

It has never been this cheap. We have no record of a lower price.

£68 today · cheaper than every other day in the last 3 months

Degenerative dementias: clinical aspects, scintigraphy and cerebrospinal fluid biomarker profile

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 30 days · 30 data points (no recent data)

Historical
Generating forecast…
£68.00 £64.60 £65.96 £67.32 £68.68 £70.04 £71.40 11 August 2026 18 August 2026 25 August 2026 01 September 2026 09 September 2026
View at Amazon ↗

Price data last checked 61 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 30 days • 1 price levels

Days at Price
30 days 0 8 15 23 30 £68 Days at Price

Price Analysis

Most common price: £68 (30 days, 100.0%)

Price range: £68 - £68

Price levels: 1 different prices over 30 days

Description

We recruited 40 patients (16 men and 24 women). The mean age of these patients was 69±11.78 years [36-86 years]. On the basis of clinical data, we suggested Alzheimer's disease (AD) in 26 patients, frontotemporal lobar degeneration in 7, dementia with Lewy bodies (MLD) in 4, and 3 patients were classified in the group of other types of dementia (progressive supra-nuclear palsy, cortico-basal degeneration and multisystematic atrophy). For AD, the sensitivity and specificity of the 3 biomarkers (Aβ (1-42), T-tau and P-tau) were 82% and 100% respectively. Concordance between neuropsychological test results, scintigraphic appearance and biomarker profile was noted in 77.5% of cases. MIBG myocardial scintigraphy was of interest in the diagnosis of In DD, no single examination proved of sufficient value to pinpoint the etiology. Convergent data from certain paraclinical examinations are necessary in early and atypical forms, particularly in cases of persistent diagnostic doubt.

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
18 June 2025
Listed Since
21 June 2025

Barcode

No barcode data available

Similar Products You Might Like

A Clinical Guide to Alzheimer's Disease
88% match

A Clinical Guide to Alzheimer's Disease

£113.51 27 Oct 2026
Chronic kidney disease overview
88% match

Chronic kidney disease overview

£68.00 04 Nov 2026
Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers
88% match

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Springer

£89.28 26 Oct 2026
Imaging Dementia: Essentials for Clinical Practice
88% match

Imaging Dementia: Essentials for Clinical Practice

Springer

£73.14 20 Oct 2026
Neurodegenerative Disease: From Molecular Basis to Therapy
87% match

Neurodegenerative Disease: From Molecular Basis to Therapy

£77.92 05 Nov 2026
Diagnostic and Therapeutic Advances in Alzheimer's Disease
87% match

Diagnostic and Therapeutic Advances in Alzheimer's Disease

£110.56 27 Oct 2026
Depression in childhood: Ontogenesis and clinical dynamics
87% match

Depression in childhood: Ontogenesis and clinical dynamics

£67.15 02 Sep 2026
The Molecular and Clinical Pathology of Neurodegenerative Diseases
87% match

The Molecular and Clinical Pathology of Neurodegenerative Diseases

£111.93 29 Oct 2026
A Clinician's Guide to Neurodegenerative Disorders
87% match

A Clinician's Guide to Neurodegenerative Disorders

£123.41 27 Oct 2026
Models of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)
87% match

Models of Neurodegenerative Diseases (Contemporary Clinical Neuroscience)

Springer

£184.81 26 Aug 2026
Molecular Imaging of Neurodegenerative Disorders
87% match

Molecular Imaging of Neurodegenerative Disorders

Springer

£73.35 07 Nov 2026
ORAL HYGIENE AND SYSTEMIC DISEASE
87% match

ORAL HYGIENE AND SYSTEMIC DISEASE

£66.00 24 Oct 2026
Neurological Disorders: Insights into Disease Biology (Neuroscience of Neurodegenerative Disease)
87% match

Neurological Disorders: Insights into Disease Biology (Neuroscience of Neurodegenerative Disease)

CRC Press

£164.00 26 Oct 2026
Parkinson's Disease: From Clinical Aspects to Molecular Basis
86% match

Parkinson's Disease: From Clinical Aspects to Molecular Basis

£113.46 27 Oct 2026
Unravelling Alzheimer’s: Innovations in Pathogenesis, Diagnosis, and Therapeutics
86% match

Unravelling Alzheimer’s: Innovations in Pathogenesis, Diagnosis, and Therapeutics

£96.94 21 Oct 2026
Unravelling Alzheimer’s: Innovations in Pathogenesis, Diagnosis, and Therapeutics
86% match

Unravelling Alzheimer’s: Innovations in Pathogenesis, Diagnosis, and Therapeutics

£96.94 20 Oct 2026
Clinical Neurology: Role of Biomarkers
86% match

Clinical Neurology: Role of Biomarkers

£116.96 04 Nov 2026
Determinants of delinquency and bank credit risk management
86% match

Determinants of delinquency and bank credit risk management

£52.00 10 Sep 2026
Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach
86% match

Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach

£82.80 08 Nov 2026
Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias
86% match

Neuroimaging Diagnosis for Alzheimer's Disease and Other Dementias

Springer

£88.21 26 Oct 2026
Nanotherapeutics for Treating Neurodegenerative Disorders
86% match

Nanotherapeutics for Treating Neurodegenerative Disorders

Elsevier

£113.44 21 Oct 2026
Living with Dementia: Neuroethical Issues and International Perspectives (Advances in Neuroethics)
86% match

Living with Dementia: Neuroethical Issues and International Perspectives (Advances in Neuroethics)

Springer

£84.48 26 Oct 2026
Optical Coherence Tomography in Multiple Sclerosis: Clinical Applications
86% match

Optical Coherence Tomography in Multiple Sclerosis: Clinical Applications

Springer

£88.21 20 Oct 2026
Hydrocephalus: From Diagnosis to Treatment (Neurology - Laboratory and Clinical Research Developments)
86% match

Hydrocephalus: From Diagnosis to Treatment (Neurology - Laboratory and Clinical Research Developments)

£67.64 29 Oct 2026